Skip to content
★ Sign in to follow
교보

교보증권 Stock: price and insider trades · South Korea

KR·Mcap ₩903.2BBanks

No insider purchase over the last 90 days. The latest, by 교보생명보험, was filed 06 Sept 2023.

교보증권: what insiders have been doing

This page follows insider dealings at 교보증권 as filed with DART (FSS), a company from the Banks sector. From 1 November 2025 to 1 November 2026, the disclosure feed for 교보증권 logged 1 filing by 1 insider.

Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

There has been no open-market purchase by an insider of 교보증권 for at least a year.

With 1 filing in twelve months, the company is quieter than the median of 7 filings across the 2,655 companies we follow on the same exchange. Our records for 교보증권 go back to 2021, with 7 purchases and no sales on the open market in total.

Elsewhere in the same sector, our signals recently picked up insider purchases at BAWAG Group AG and Linc AB. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.

Insider Decl.
16
Thresholds
n/a
Buy Volume
€174M
7 ops. · all time
Sell Volume
n/a
n/a

Since the insiders bought

  • Filed 06 Sept 2023 · 1161 days ago · €173.8M
    +3.6%
    Entry ₩5,020 · Close at T+365 ₩5,200

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 10,851 of 26,911 companies
56.4
score / 100
Value
56
Quality
57
FCF yld-106%
Earn yld17%
EV/EBITDA7.3x
ROE8.9%
Gross mgn·
Net mgn31%
Debt/EBITDA5.3x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

₩8,000
Analyst consensus
·
Income statement
Revenue₩465.2B
EBITDA₩411.6B88% margin
Net income₩142.9B2.9% margin
Valuation
Beta0.97
Balance sheet & cash
Market cap₩903.2B
Total debt₩2.2T
Free Cash Flow-₩909.9B
Debt / Equity343%
Profitability & ownership
ROE8.9%
ROA1.0%
% insiders0.1%
% institutions86.2%
Last declaration on 11 March 2026
Declarations17 total
  • Other
    Other(filed)
    0DART
  • ●
    Executives
    Executives(filed)
    0DART
  • ▲
    Related company / holdingExecutives
    250B KRW10DART
    49,309,665 shares@ ₩5,070.00100.0% of flowShareKRXDART:20230906000236
    Canonical exit: 29 Nov 2023 (T+90)
  • ▲
    Related company / holdingExecutives
    0DART
    49,368,013 sharesKRXDART:20230906000223
    Canonical exit: 29 Nov 2023 (T+90)
  • ●
    Executives
    Executives(filed)
    0DART
  • ▲
    Executives
    €9,873est.0DART
    2,500 sharesShareKRXDART:20221109000001
    Canonical exit: 5 Feb 2023 (T+90)
  • ▲
    Executives
    €9,666est.0DART
    2,500 sharesShareKRXDART:20221108000007
    Canonical exit: 6 Feb 2023 (T+90)
  • ▲
    Executives
    €19kest.0DART
    5,000 sharesShareKRXDART:20221107000352
    Canonical exit: 5 Feb 2023 (T+90)
  • ▲
    Executives
    €32kest.0DART
    8,400 sharesShareKRXDART:20221107000007
    Canonical exit: 5 Feb 2023 (T+90)
  • ▲
    Executives
    €16kest.0DART
    3,465 sharesShareKRXDART:20220913000293
    Canonical exit: 12 Dec 2022 (T+90)
  • ●
    Executives
    Executives(filed)
    0DART
  • ●
    Executives
    Executives(filed)
    0DART
  • ●
    Executives
    Executives(filed)
    0DART
  • ●
    Executives
    Executives(filed)
    0DART
  • ●
    Executives
    Executives(filed)
    0DART
  • ●
    Executives
    Executives(filed)
    0DART
  • ●
    Executives
    Executives(filed)
    0DART

17 of 17 declarations

About 교보증권

교보증권 is a South Korean financial services company that specializes in brokerage and investment services. It is listed on the XKRX.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations